The use of oral anticoagulation therapy to prevent stroke in patients with atrial fibrillation (AF) is one of the most successful therapies in cardiovascular and stroke medicine. 1 The introduction of direct oral anticoagulants has increased the ease and safety of delivering this therapy 1 ; thus, there is a strong motivation to deliver this therapy to patients at risk of AFrelated stroke. More than 2 million cardiac surgeries are performed each year, and 20% to 30% of these patients develop postoperative AF. 2 Although most of these patients have traditional AF and stroke risk factors, 2 it is postulated that much of this AF may be transient, the result of both local inflammation and a systemic inflammatory response. 3 Clinicians speculate that AF may be self-limited in patients following cardiac surgery similar to other situations of transient stress, such as medical illness and noncardiac surgery, 4 and thus longterm treatment with oral anticoagulation therapy may not be necessary.Previous studies 5,6 using administrative data have attempted to determine the long-term risk of stroke in patients with AF following cardiac surgery. In nearly 109 000 patients who underwent cardiac surgery between 1996 and 2006 in Ontario, Canada, 5 1.8% experienced a stroke perioperatively and 3.6% experienced a stroke in the ensuing 2 years. Atrial fibrillation was present preoperatively in 9574 patients (8.8%), and new postoperative AF developed in 18 046 (18.2%). After multivariable adjustment, postoperative AF was significantly associated with an increased risk of perioperative stroke (hazard ratio [HR], 1.5; 95% CI, 1.3-1.6) but not stroke following hospital discharge (HR, 1.1; 95% CI, 1.0-1.2). 5 In 2014, Gialdini et al 6 used administrative data from California to study patients after both cardiac and noncardiac surgery, nearly 25 000 of whom developed postoperative AF and nearly 14 000 of whom experienced a stroke. After multivariable adjustment, postoperative AF was associated with an increased risk of developing stroke following cardiac surgery (HR, 1.3; 95% CI, 1.1-1.6) and after noncardiac surgery (HR, 2.0; 95% CI, 1.7-2.3; P < .001). 6 Together, these 2 large cohort studies suggest that AF following cardiac surgery is associated with a more modest risk of later stroke than is seen early after surgery and compared with other types of surgery, raising the possibility that long-term oral anticoagulation therapy may not always be necessary in this setting.In this issue of JAMA Cardiology, Butt et al 7 used the Danish National Patient Registry to identify 2108 patients with AF